HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Theodora Hatziioannou Selected Research
Theodora Hatziioannou Research Topics
Disease
44
COVID-19
02/2024 - 01/2020
42
Infections
10/2023 - 06/2002
5
Virus Diseases (Viral Diseases)
02/2024 - 01/2007
4
Severe Acute Respiratory Syndrome
01/2024 - 01/2021
4
Vesicular Stomatitis
12/2021 - 10/2019
4
Acquired Immunodeficiency Syndrome (AIDS)
10/2014 - 10/2006
3
Breakthrough Infections
12/2022 - 10/2021
3
Reinfection
01/2022 - 01/2021
2
Pneumonia (Pneumonitis)
01/2021 - 01/2021
1
Convalescence
10/2021
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021
1
Viral Zoonoses
02/2009
1
Fasciculation (Fasciculations)
05/2005
Drug/Important Bio-Agent (IBA)
32
Antibodies
IBA
02/2024 - 04/2007
22
Neutralizing Antibodies
IBA
02/2024 - 07/2020
19
Vaccines
IBA
10/2022 - 10/2006
8
Epitopes
IBA
01/2023 - 04/2007
7
Monoclonal Antibodies
IBA
01/2023 - 06/2020
7
Messenger RNA (mRNA)
IBA
01/2023 - 01/2021
6
Proteins (Proteins, Gene)
FDA Link
01/2024 - 05/2005
6
mRNA Vaccines
IBA
12/2022 - 06/2021
6
Antigens
IBA
08/2022 - 01/2021
5
Antiviral Agents (Antivirals)
IBA
01/2021 - 06/2020
4
Single-Domain Antibodies
IBA
12/2021 - 01/2021
2
Glycoproteins (Glycoprotein)
IBA
02/2024 - 06/2023
2
Polysaccharides (Glycans)
IBA
01/2024 - 06/2023
2
N-(2-cyanoethylene)urea (BA 1)
IBA
10/2023 - 12/2022
2
BNT162 Vaccine
IBA
12/2021 - 10/2021
2
Explosive Agents (Explosives)
IBA
11/2020 - 06/2020
2
env Gene Products
IBA
01/2016 - 10/2014
2
Bone Marrow Stromal Antigen 2
IBA
06/2014 - 02/2009
2
Complementary DNA (cDNA)
IBA
03/2008 - 01/2007
1
COVID-19 Vaccines
IBA
01/2022
1
Angiotensin-Converting Enzyme 2
IBA
12/2021
1
2019-nCoV Vaccine mRNA-1273
IBA
10/2021
1
crexavibart
IBA
01/2021
1
ogalvibart
IBA
01/2021
1
Immunoglobulin A (IgA)
IBA
01/2021
1
Enzymes
IBA
11/2020
1
Immunosorbents
IBA
11/2020
1
Immunoglobulins (Immunoglobulin)
IBA
01/2020
1
Broadly Neutralizing Antibodies
IBA
01/2016
1
Interferons
IBA
10/2013
1
Cyclophilin A
IBA
03/2008
1
moesin
IBA
01/2007
1
Tripartite Motif Proteins
IBA
09/2006
1
Carrier Proteins (Binding Protein)
IBA
05/2005
1
Protein Kinase C
IBA
05/2005
1
Circular DNA
IBA
05/2005
1
Viral DNA
IBA
05/2005
1
Antiviral Restriction Factors
IBA
06/2004
1
Capsid Proteins (Capsid Protein)
IBA
06/2004
1
Peptide Hydrolases (Proteases)
FDA Link
09/2002
1
polycations
IBA
06/2002
1
Cyclophilins (Cyclophilin)
IBA
06/2002
1
polyanions
IBA
06/2002
1
Glycosaminoglycans
IBA
06/2002
Therapy/Procedure
4
Therapeutics
01/2023 - 12/2012
1
Immunotherapy
01/2021
1
Highly Active Antiretroviral Therapy (HAART)
01/2019
1
Chemoprevention
03/2009